Reacción #164766

ord-c1be57b819f647ad868cc9d5dc5b305e

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    ExtracciónThe mixture is extracted with ethyl acetate (3×)
  2. 2
    SecadoThe combined organic extracts are dried over sodium sulfate
  3. 3
    Filtraciónfiltered
  4. 4
    Otrothe solvent removed in vacuo
  5. 5
    OtroThe crude product is purified over silica gel with a 20 minute 5% to 100% ethyl acetate in hexanes gradient

Procedimiento

N-[(4aR,7aS)-7a-(3-Aminophenyl)-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-2-yl]benzamide (400 mg, 891.81 μmole) and 5-methoxypyrazine-2-carboxylic acid (165 mg, 1.07 mmol) are combined in dichloromethane (4 mL) and dimethylformamide (0.5 mL). 1-Hydroxybenzotriazole (160 mg, 1.16 mmol) and then 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (226 mg, 1.16 mmol) are added and the resulting mixture is stirred for 5 hours at room temperature under nitrogen. The reaction mixture is diluted with water and the pH is adjusted to ˜12 with 1 N NaOH. The mixture is extracted with ethyl acetate (3×). The combined organic extracts are dried over sodium sulfate, filtered and the solvent removed in vacuo. The crude product is purified over silica gel with a 20 minute 5% to 100% ethyl acetate in hexanes gradient to give the title compound (482 mg, 92%). ES/MS (m/e): 585 (M+H).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US08841293B1uspto-grants-2014_09